-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Fl91hnaOnQ0qvDbHtWWfN6c33kIv1FOUSEWbdCdxuP3pfGNIevrfSwNTRSYCz/zc
 xpzPQwIDd3L7JxeKUWweIw==

<SEC-DOCUMENT>0001144204-09-020201.txt : 20090413
<SEC-HEADER>0001144204-09-020201.hdr.sgml : 20090413
<ACCEPTANCE-DATETIME>20090413175831
ACCESSION NUMBER:		0001144204-09-020201
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090401
FILED AS OF DATE:		20090413
DATE AS OF CHANGE:		20090413

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Marguglio David J.
		CENTRAL INDEX KEY:			0001461753

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26372
		FILM NUMBER:		09747348

	MAIL ADDRESS:	
		STREET 1:		2658 DEL MAR HEIGHTS RD., #555
		CITY:			DEL MAR
		STATE:			CA
		ZIP:			92014

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adamis Pharmaceuticals Corp
		CENTRAL INDEX KEY:			0000887247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820429727
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2085?B? QUAKER POINT DRIVE
		CITY:			QUAKERTOWN
		STATE:			PA
		ZIP:			18951
		BUSINESS PHONE:		215-529-6084

	MAIL ADDRESS:	
		STREET 1:		2085?B? QUAKER POINT DRIVE
		CITY:			QUAKERTOWN
		STATE:			PA
		ZIP:			18951

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLEGY PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950615
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>v146073_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-04-01</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000887247</issuerCik>
        <issuerName>Adamis Pharmaceuticals Corp</issuerName>
        <issuerTradingSymbol>CLGY</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001461753</rptOwnerCik>
            <rptOwnerName>Marguglio David J.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADAMIS PHARMACEUTICALS CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>2658 DEL MAR HEIGHTS ROAD, #555</rptOwnerStreet2>
            <rptOwnerCity>DEL MAR</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92014</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3439904</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Reflects post-split shares from the reverse split that became effective April 1, 2009.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Robert O. Hopkins Power of Attorney for David J. Marguglio</signatureName>
        <signatureDate>2009-04-10</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----